114 related articles for article (PubMed ID: 7582512)
1. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice.
Collins DR; Pertwee RG; Davies SN
Br J Pharmacol; 1995 Jul; 115(6):869-70. PubMed ID: 7582512
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
Terranova JP; Michaud JC; Le Fur G; Soubrié P
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):576-9. PubMed ID: 8751088
[TBL] [Abstract][Full Text] [Related]
3. Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal slice.
Paton GS; Pertwee RG; Davies SN
Neuropharmacology; 1998 Sep; 37(9):1123-30. PubMed ID: 9833642
[TBL] [Abstract][Full Text] [Related]
4. Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
Hoffman AF; Oz M; Yang R; Lichtman AH; Lupica CR
Learn Mem; 2007; 14(1-2):63-74. PubMed ID: 17202425
[TBL] [Abstract][Full Text] [Related]
5. The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice.
Collins DR; Pertwee RG; Davies SN
Eur J Pharmacol; 1994 Jul; 259(3):R7-8. PubMed ID: 7982446
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro.
Lees G; Dougalis A
Brain Res; 2004 Jan; 997(1):1-14. PubMed ID: 14715144
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus.
Kirby MT; Hampson RE; Deadwyler SA
Brain Res; 2000 Apr; 863(1-2):120-31. PubMed ID: 10773200
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
[TBL] [Abstract][Full Text] [Related]
9. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
Welch SP; Huffman JW; Lowe J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392
[TBL] [Abstract][Full Text] [Related]
10. Modulation of ATP-induced LTP by cannabinoid receptors in rat hippocampus.
Ievglevskyi O; Palygin O; Kondratskaya E; Grebenyuk S; Krishtal O
Purinergic Signal; 2012 Dec; 8(4):705-13. PubMed ID: 22453905
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist.
Hirst RA; Almond SL; Lambert DG
Neurosci Lett; 1996 Dec; 220(2):101-4. PubMed ID: 8981483
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats.
Hampson RE; Deadwyler SA
J Neurosci; 2000 Dec; 20(23):8932-42. PubMed ID: 11102504
[TBL] [Abstract][Full Text] [Related]
13. Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal.
Beardsley PM; Martin BR
Eur J Pharmacol; 2000 Jan; 387(1):47-53. PubMed ID: 10633159
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons.
Hampson RE; Simeral JD; Kelly EJ; Deadwyler SA
Hippocampus; 2003; 13(5):543-56. PubMed ID: 12921345
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers.
Rodríguez de Fonseca F; Roberts AJ; Bilbao A; Koob GF; Navarro M
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1109-14. PubMed ID: 11189201
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
17. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide.
Cani PD; Montoya ML; Neyrinck AM; Delzenne NM; Lambert DM
Br J Nutr; 2004 Nov; 92(5):757-61. PubMed ID: 15533263
[TBL] [Abstract][Full Text] [Related]
18. The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat.
Chapman V
Br J Pharmacol; 1999 Aug; 127(8):1765-7. PubMed ID: 10482905
[TBL] [Abstract][Full Text] [Related]
19. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol.
Tanda G; Loddo P; Di Chiara G
Eur J Pharmacol; 1999 Jul; 376(1-2):23-6. PubMed ID: 10440085
[TBL] [Abstract][Full Text] [Related]
20. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.
Lichtman AH; Martin BR
Psychopharmacology (Berl); 1996 Jul; 126(2):125-31. PubMed ID: 8856831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]